A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Transthyretin Amyloidosis Polyneuropathy · Transthyrexin Amyloidosis Cardiomyopathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
The First Affiliated Hospital, School of Medicine, Zhejiang University, Hanzhou, Zhejiang, China